Mandel Vision Newsletter ~ In Focus ~ November 2021

Mandel Vision ~ In Focus ~ November 2021 Highlights

Learn about flexible spending and LASIK, a new treatment option for chronic dry eye, iDesign LASIK technology and the customization of LASIK surgery in this month’s In Focus Newsletter.

It’s Flexible Spending Time!

If you’re thinking about LASIK and are lucky enough to have an FSA (Flexible Spending Account), you’ll need to contribute to the account soon in order to use those dollars in 2021.

Click here to read the full blog post.

This month’s Featured Eye Health Tip

The FDA has approved a first-of-its-kind nasal spray to treat chronic dry eye disease. Tyrvaya is a cholinergic agonist, and works by activating a nerve pathway that can increase the amount of tear film that normally helps lubricate the eye.* This is great news for patients with dry eye syndrome who have tried other therapies without success.



What is the iDesign Refractive Studio and how does it help achieve better results with LASIK and PRK?

The iDesign Refractive Studio is the latest generation in customized LASIK treatments.  Mandel Vision is proud to be the first practice in New York to offer this state-of-the-art technology to our LASIK patients. This technology uses a proprietary INSIDE+OUT approach that combines both corneal topography measurements and wavefront analysis.

Click here to read more about this revolutionary technology.

New on the Blog

All About LASIK with Dr. Eric Mandel – Video Blog Series – Part 1

In part one of our video blog series, All About LASIK with Dr. Eric Mandel, Dr. Mandel educates patients about the importance of customizing each patient’s LASIK surgery.

Click here to read the full blog post.

This entry was posted in News. Bookmark the permalink.